Astrana Health (ASTH) versus Its Peers Head to Head Review

Astrana Health (NASDAQ:ASTH) is one of 65 public companies in the “Management consulting services” industry, but how does it contrast to its competitors? We will compare Astrana Health to similar companies based on the strength of its valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.

Profitability

This table compares Astrana Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	4.49%	11.52%	6.67%
Astrana Health Competitors	-68.13%	-348.99%	-12.79%

Institutional and Insider Ownership

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 45.2% of shares of all “Management consulting services” companies are owned by institutional investors. 8.5% of Astrana Health shares are owned by insiders. Comparatively, 28.8% of shares of all “Management consulting services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Astrana Health and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Astrana Health	$1.39 billion	$60.72 million	31.15
Astrana Health Competitors	$1.64 billion	$114.49 million	11.20

Astrana Health’s competitors have higher revenue and earnings than Astrana Health. Astrana Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

Astrana Health has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500. Comparatively, Astrana Health’s competitors have a beta of 0.89, suggesting that their average share price is 11% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Astrana Health and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	1	1	0	2.50
Astrana Health Competitors	68	530	1407	58	2.71

Astrana Health currently has a consensus target price of $47.00, indicating a potential upside of 14.30%. As a group, “Management consulting services” companies have a potential upside of 18.47%. Given Astrana Health’s competitors stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health has less favorable growth aspects than its competitors.

Summary

Astrana Health competitors beat Astrana Health on 7 of the 13 factors compared.

About Astrana Health

Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient and physician alignment solutions. The company focuses on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings, Inc. is headquartered in Glendale, CA.